Assembly Biosciences Inc (ASMB)
13.18
-0.30
(-2.23%)
USD |
NASDAQ |
Apr 25, 16:00
13.18
0.00 (0.00%)
After-Hours: 20:00
Assembly Biosciences Cash from Operations (TTM): 22.74M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 22.74M |
September 30, 2023 | -70.16M |
June 30, 2023 | -76.13M |
March 31, 2023 | -80.39M |
December 31, 2022 | -84.46M |
September 30, 2022 | -84.57M |
June 30, 2022 | -83.63M |
March 31, 2022 | -87.55M |
December 31, 2021 | -93.40M |
September 30, 2021 | -99.30M |
June 30, 2021 | -69.78M |
March 31, 2021 | -71.08M |
December 31, 2020 | -62.96M |
September 30, 2020 | -58.22M |
June 30, 2020 | -87.46M |
March 31, 2020 | -85.35M |
December 31, 2019 | -84.07M |
September 30, 2019 | -80.27M |
June 30, 2019 | -78.36M |
March 31, 2019 | -73.40M |
December 31, 2018 | -64.96M |
September 30, 2018 | -58.00M |
June 30, 2018 | -52.27M |
March 31, 2018 | -48.58M |
December 31, 2017 | 1.86M |
Date | Value |
---|---|
September 30, 2017 | 0.5906M |
June 30, 2017 | 3.684M |
March 31, 2017 | 9.273M |
December 31, 2016 | -34.88M |
September 30, 2016 | -29.30M |
June 30, 2016 | -26.62M |
March 31, 2016 | -24.23M |
December 31, 2015 | -18.70M |
September 30, 2015 | -16.84M |
June 30, 2015 | -15.52M |
March 31, 2015 | -13.46M |
December 31, 2014 | -14.97M |
September 30, 2014 | -16.77M |
June 30, 2014 | -17.55M |
March 31, 2014 | -18.61M |
December 31, 2013 | -17.80M |
September 30, 2013 | -15.47M |
June 30, 2013 | -16.10M |
March 31, 2013 | -19.66M |
December 31, 2012 | -21.38M |
September 30, 2012 | -34.64M |
June 30, 2012 | -33.43M |
March 31, 2012 | -29.34M |
December 31, 2011 | -25.07M |
September 30, 2011 | -9.955M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-99.30M
Minimum
Sep 2021
22.74M
Maximum
Dec 2023
-74.44M
Average
-80.39M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
Petros Pharmaceuticals Inc | -7.626M |
Spectral AI Inc | -- |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |